Excellergy

San Jose, CA · Founded 2020 · Privately Held (backing)

Developer of protein therapeutics designed to combat severe allergic diseases. Excellergy is based in San Jose, CA and was founded in 2020. Its last known valuation is $122 million. It has raised $79.8 million.

Last price · $/share
—
Implied valuation
$122.2M
Total raised
$79.8M
Last round
—
What is Excellergy worth?
$122.2Mlast known valuation
Free account
More of Excellergy with a free account
  • ·Watch Excellergy: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Excellergy funding history

No rounds on record

No funding rounds for Excellergy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Excellergy valuation

Excellergy's last known valuation is $122 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Excellergy's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Excellergy, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Excellergy

What is Excellergy worth?
Excellergy's last known valuation is $122.2M.
How much has Excellergy raised?
Excellergy has raised $79.8M in total funding across its recorded rounds.